Global Hemostats Market Worth USD 4.5 Billion By 2024

Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024

The global hemostats market has accounted to USD 2.7 billion in 2016, and is expected to reach USD 4.5 billion by 2024, growing at a CAGR of 6.5% in the forecast period 2017 to 2024.

Request for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample?dbmr=global-hemostats-market-trends-forecast-2024

The global hemostats market is segmented into based on product type, indication, end-user and geography.

On the basis of product types the global hemostats market is segmented into 5 product type’s thrombin based hemostats, combination agents hemostats, oxidized regeneration cellulose based hemostats, gelatin based hemostats and collagen based segments. The market report covers market value and volume of the segments mentioned earlier. In 2015, in terms of market value the thrombin based hemostats market segment dominates the market with 34.1% market share. While the combination based hemostats market is expected to grow at the highest CAGR in the forecast period of 2016 to 2022. In terms of volume the hemostats market is dominated by thrombin based hemostats with 41.7% market share in 2015.

The global hemostats market is further segmented based on indications into wound closure and surgery. The surgery segment dominates the market in 2015.

The global hemostats market is further segmented on the basis of end users into hospitals, clinics, ambulatory centers, community healthcare and others.

Inquiry before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying?dbmr=global-hemostats-market-trends-forecast-2024

The global hemostats market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. Some of the recent developments in the hemostats market are: April 2015, Ethicon’s fibrin sealant patch received food and drug administration approval for extended surgical indications; April 2016, 3-D Matrix Europe subsidiary entered partnership with Chile based M. Kaplan Y CIA LTDA. for sistribution rights of PuraStat hemostat of 3-D Matrix in Chile. The global hemostats market report also contains market share by manufacturer’s data for U.S., Canada, Brazil, Mexico, Germany, France, U.K., China, India, Japan, North America, South America, Europe, Asia-Pacific and Middle East and Africa.

Based on geography the Global Hemostats Market is segmented into:

• North America
• South America
• Europe
• Asia-Pacific
• Middle East and Africa

Browse Full Report Visit @ http://databridgemarketresearch.com/reports/medical-devices/general-surgery-medical-devices/global-hemostats-market-trends-forecast-2024

Some of the major companies operating in this market are:

• Pfizer
• C.R. Bard
• Baxter
• Vascular Solutions, Inc.
• B.Braun Melsungen
• 3-D Matrix, Ltd.
• Resorba Medical GmbH (A Advanced Medical Solutions Group plc Company)
• Anika Therapeutics, Inc.
• Arch Therapeutics Inc.
• Biom’Up SAS
• CryoLife, Inc.
• Gamma Therapeutics, Inc.
• Hemostasis, LLC
• Medtrade Products Ltd.
• Integra Lifesciences Corporation
• Medline Industries, Inc.
• Hemotec Medical GmbH
• Stryker
• Hemostasis
• LLC.
• CSL Behring
• Mallinckrodt plc.
• Equimedical, B.V.

Table of Content:

1. INTRODUCTION
1.1. OVERVIEW OF THE HEMOSTATS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL HEMOSTATS MARKET
2.3. GLOBAL HEMOSTATS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL HEMOSTATS MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. HEMOSTATS MARKET, BY PRODUCT TYPE
6. HEMOSTATS MARKET, BY INDICATION
7. HEMOSTATS MARKET, BY END-USER
8. HEMOSTATS MARKET, BY GEOGRAPHY
8.1. COUNTRYWISE HEMOSTATS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
8.1.1. NORTH AMERICA
8.1.2. EUROPE
8.1.3. ASIA-PACIFIC (APAC)
8.1.4. LATIN AMERICA
8.1.5. MIDDLE EAST AND AFRICA
8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
9. HEMOSTATS MARKET: COMPETITIVE LANDSCAPE
9.1. GLOBAL HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
9.2. U.S. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
9.3. EUROPE HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
9.4. ASIA-PACIFIC HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
9.5. MERGERS & ACQUISITIONS
9.6. NEW PRODUCT DEVELOPMENT & APPROVALS
9.7. EXPANSIONS
9.8. REGULATORY CHANGES
9.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
10. HEMOSTATS MARKET, COMPANY PROFILES
10.1. ETHICON, INC. (A JOHNSON AND JOHNSON COMPANY)
10.2. PFIZER
10.3. C.R. BARD
10.4. BAXTER
10.5. VASCULAR SOLUTIONS, INC.
10.6. B.BRAUN MELSUNGEN
10.7. 3-D MATRIX, LTD
10.8. RESORBA MEDICAL GMBH (A ADVANCED MEDICAL SOLUTIONS GROUP PLC COMPANY)
10.9. ANIKA THERAPEUTICS, INC.
10.10. ARCH THERAPEUTICS INC.
10.11. BIOM’UP SAS
10.12. CRYOLIFE, INC.
10.13. GAMMA THERAPEUTICS, INC.
10.14. HEMOSTASIS, LLC
10.15. MEDTRADE PRODUCTS LTD.
10.16. INTEGRA LIFESCIENCES CORPORATION
10.17. MEDLINE INDUSTRIES, INC.
10.18. HEMOTEC MEDICAL GMBH
10.18.1. OVERVIEW
10.18.2. SWOT ANALYSIS
10.18.3. PRODUCT PORTFOLIO
10.18.4. REVENUE ANALYSIS
10.18.5. ANALYSTS VIEW
10.19. STRYKER
10.19.1. OVERVIEW
10.19.2. SWOT ANALYSIS
10.19.3. PRODUCT PORTFOLIO
10.19.4. REVENUE ANALYSIS
10.19.5. ANALYSTS VIEW
10.20. HEMOSTASIS, LLC.
10.20.1. OVERVIEW
10.20.2. SWOT ANALYSIS
10.20.3. PRODUCT PORTFOLIO
10.20.4. REVENUE ANALYSIS
10.20.5. ANALYSTS VIEW
10.21. CSL BEHRING
10.21.1. OVERVIEW
10.21.2. SWOT ANALYSIS
10.21.3. PRODUCT PORTFOLIO
10.21.4. REVENUE ANALYSIS
10.21.5. ANALYSTS VIEW
10.22. MALLINCKRODT PLC.
10.22.1. OVERVIEW
10.22.2. SWOT ANALYSIS
10.22.3. PRODUCT PORTFOLIO
10.22.4. REVENUE ANALYSIS
10.22.5. ANALYSTS VIEW
10.23. EQUIMEDICAL, B.V.
10.23.1. OVERVIEW
10.23.2. SWOT ANALYSIS
10.23.3. PRODUCT PORTFOLIO
10.23.4. REVENUE ANALYSIS
10.23.5. ANALYSTS VIEW

Related Report

Global Medical Instruments Disinfections Market – Trends and Forecast to 2024

Global Medical Instruments Disinfection Market, By Product Type (Disinfectants (Wipes, Sprays, Liquid), Disinfectors, Endoscopic Reprocessors), End-Users, By Distribution Channel, By Geography (North America, Europe, Asia-Pacific, South America and Middle East and Africa) – Trends and Forecast to 2024

Report Access:
http://databridgemarketresearch.com/reports/medical-devices/healthcare-manufacturing/global-medical-instruments-disinfections-market-trends-forecast-2024/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research